American Realty Capital (ARC) New York City Real Estate Investment Trust Investigation
The securities litigation attorneys at Colling Gilbert Wright & Carter are currently investigating the American Realty Capital (ARC) New York City Real Estate Investment Trust. If you are a retail investor whose broker recommended that you invest in American Realty Capital (ARC) New York City Real Estate Investment Trust (REIT) or other ARC related REITs, you may have grounds for an unsuitable investment recommendation or lack of due diligence claim.
ARC NYC REIT is a risky, speculative investment that is inappropriate for most individual investors, especially inexperienced investors, conservative investors, seniors, or retirees. Although initially a non-traded real estate investment trust (non-traded REIT), the formerly illiquid investment went public on the New York Stock Exchange (NYSE) in August 2021.
The public offering share price fell on the first day. Despite an initial offering price of $25/share, after the offering the company’s board of directors gave its approval for a 2.43 to 1 reverse split. This corporate action resulted in a significant decline leading to some investors experiencing a loss of the majority of their investment.
Claims for losses such as this are contractually required to be brought in Financial Industry Regulatory Authority (FINRA) arbitration. If you invested in any of the following ARC-related REIT products, please contact our experienced securities arbitration attorneys for a complimentary case evaluation. We represent individual investors nationwide.
ARC NYC REIT
ARC Hospitality REIT
Healthcare Income Trust (HIT)
ARC Capital Healthcare Trust
American Realty Capital
Global Net Lease, Inc.